Healthcare

Facial Injectable Market Share, Upcoming Trends, Size, Key Segments, Growth Status and Forecast 2030

Share This Article

The facial injectable market was valued at USD 12.25 billion in 2021 and is projected to reach $28.13 billion by 2030, growing at a CAGR of 9.7% from 2022 to 2030.

The dermal fillers often known as facial injectables, are treatments that help with facial rejuvenation. These injectable face solutions are primarily intended to alleviate early indicators of ageing such as wrinkles and to enhance aesthetic appearance.

Download Exclusive Sample of Report@ https://www.precedenceresearch.com/sample/1594

There has been a significant growth in disposable incomes worldwide, as well as rise in aesthetic attractiveness consciousness. As a result, as more people choose to improve their physical appearances, attitudes around cosmetic operations have shifted. A growing number of people are choosing for minimally invasive procedures like facial injectables since they are considered safer and require little to no delay. The neurotoxins like botulinum toxin as well as dermal fillers like hyaluronic acid and calcium hydroxylaptite are among the facial injectables available in the market.

The need for cosmetic procedures is being driven by an increase in the number of plastic surgeons and their networks, which is in turn increasing the demand for facial injectables. There was also Food & Drug Administration (FDA) authorization for other practitioners including as surgeons to utilize facial injectable in their clinics. The healthcare practitioners can now perform facial injectable procedures because they encounter many patients requiring facial transformation after dental treatments. The facial injectable market is likely to develop as a result of this factor.

Report Scope of the Facial Injectable Market

Report Coverage Details
Market Size by 2030 USD 28.13 Billion
Growth Rate from 2022 to 2030 CAGR of 9.7%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Application, End User, Generation, Geography

Report Highlights

  • Based on the product, the botulinum toxin Type A segment dominated the global facial injectable market in 2020 with highest market share. The botulinum toxin Type A in its cosmetic version, known to patients as Botox, is a popular injection that temporarily reduces or removes facial small lines and wrinkles. The forehead creases and frown lines are the most typically treated locations.
  • North America is the largest segment for facial injectable market in terms of region. North America controlled the facial injectable market and has a high level of knowledge regarding the state of healthcare and its costs.
  • Asia-Pacific region is the fastest growing region in the facial injectable market. The higher awareness about aesthetic surgical procedures, the presence of key market players, and an increasing geriatric population, technological advancements, and demand for minimally invasive aesthetic procedures are some of the factors driving the growth of the facial injectable market in the Asia-Pacific region.

Purchase this report (Price 4500 USD for a single-user license) @ https://www.precedenceresearch.com/checkout/1594

Market Dynamics

Drivers

The surge in demand for aesthetic procedures

The increased awareness has resulted in an increase in demand for aesthetic procedures. Furthermore, as developing countries around the world improve economically, disposable income has risen dramatically. As a result, an increasing number of people are opting for various filler injections to improve their aesthetic appearance. There has also been a considerable shift in attitudes about these cosmetic treatments, reducing the stigma associated with them. As a result, the surge in demand for aesthetic procedures will drive the growth of the global facial injectable market during the forecast period.

Restraints

High cost of facial injectables

The average cost of hyaluronic acid fillers is $682 per syringe, according to American Society of Plastic Surgeons (ASPS) price data from 2018. To attain the intended results, most people will need more than one syringe. Botox, on the other hand, is sold in units and costs between $10 and $15 each unit. For example, to treat the forehead and eye area, an average dosage of 30-40 units might be employed, resulting in a total cost of $300 to $600. Thus, the high cost of facial injectables is hindering the market growth.

Opportunities

Surge in adoption of facial injectable

An increasing proportion of the male population is predicted to adopt facial injectable in the forecast period, which is one of the most unique and widespread trends in the worldwide market. During the forecast period, this particular trend is expected to contribute positively to the facial injectable market growth. Additionally, because males do not want a more apparent improvement of their facial characteristics, less invasive procedures such as botulinum toxin are a popular alternative. More males are predicted to use facial injectables rather than invasive cosmetic procedures as a result of this. The facial injectable growth is projected to be aided by such developments.

Challenges

Side effects of the treatments

The market for facial injectables is projected to be hampered by the negative effects associated with dermal injectables over the forecast period. The injection technique used by the healthcare provider, for example, can influence whether or not the patient has bruise and stiffness. The rapid filler injection and the use of large number of fillers have all been proven to enhance the risk of bruising. Furthermore, if the filler is injected too superficially, it can create a bluish discoloration of the skin covering the filler in some cases. As a result, the side effects of the treatments are a major challenge for the growth of the global facial injectable market during the forecast period.

Regional Insights

North America dominated the market and accounted for the largest revenue share of more than 41% in 2020. This growth is owing to the large geriatric population in the U.S. and Canada is anticipated to propel the demand for facial injectables over the forecast period.

In the Asia Pacific, the market is projected to witness the highest CAGR of 10% during the forecast period. The region is backed by countries such as India, Australia, and South Korea. Growing focus on the physical appearance in these developing countries is expected to play a key role in the demand for facial injectable treatment. India is projected to be the fastest-growing during the forecast period.

Some of the prominent players in the global facial injectable market include:

  • Johnson & Johnson
  • Syneron Candela
  • Lumenis
  • Hologic
  • Solta Medical
  • Alma Laser
  • Galderma
  • Dickinson and Company
  • Antares Pharma
  • Novartis AG

Segments Covered in the Report

By Product

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylaptite (CaHA)
  • Polymer Fillers
  • Others

By Application

  • Aesthetics
  • Therapeutics

End User

  • Hospitals
  • Specialty Clinics
  • Spa & Beauty Clinics

By Generation

  • Gen X
  • Boomer
  • Millennials

Regional Segmentation
Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia],
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland],
• North America [United States, Canada, Mexico],
• South America [Brazil, Argentina, Columbia, Chile, Peru].
• Middle East & Africa [GCC, North Africa, South Africa],

Why should you invest in this report?

If you are aiming to enter the global xxx market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for xxx market are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

 Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Facial Injectable Market 

5.1. COVID-19 Landscape: Facial Injectable Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Facial Injectable Market, By Product

8.1. Facial Injectable Market, by Product Type, 2022-2030

8.1.1. Collagen

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Hyaluronic Acid (HA)

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Botulinum Toxin Type A

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Calcium Hydroxylaptite (CaHA)

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Polymer Fillers

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Facial Injectable Market, By Application

9.1. Facial Injectable Market, by Application, 2022-2030

9.1.1. Aesthetics

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Therapeutics

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Facial Injectable Market, By End User

10.1. Facial Injectable Market, by End User Type, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Specialty Clinics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Spa & Beauty Clinics

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Facial Injectable Market, By Generation 

11.1. Facial Injectable Market, by Generation Type, 2022-2030

11.1.1. Gen X

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Boomer

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Millennials

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Facial Injectable Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.1.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by End User Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)

Chapter 13. Company Profiles

13.1. Johnson & Johnson

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Syneron Candela

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Lumenis

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Hologic

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Solta Medical

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Alma Laser

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Galderma

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Dickinson and Company

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Antares Pharma

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Novartis AG

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Buy Exclusive Report@ https://www.precedenceresearch.com/checkout/1594

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Related Articles

Back to top button